CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Three new companies spring to life from boron research at RTP-based Boragen
News | 02. 04. 2022
Boragen
Research Triangle Park-based Boragen to be split into three different companies, one focused on crop protection, one on animal health, and the other on human health.
